Oncology Roadmap (TA220)
Brand Spending Benchmarks and Market Forecast to 2013
Published 2008
424 Pages
89 Companies
130+ Oncology Products
14 Company Portfolio Profiles
1000+ Metrics
900+ Charts and Diagrams
424 Pages
89 Companies
130+ Oncology Products
14 Company Portfolio Profiles
1000+ Metrics
900+ Charts and Diagrams
Download Complimentary Report Summary
Give Your Team Access to the Most Comprehensive Oncology Forecast Ever Created
Cutting Edge Information's new report, Oncology Roadmap: Brand Spending Benchmarks and Market Forecast to 2013, explores the fiercely competitive oncology market in a way that no other available forecast can match.
Our experienced analysts have reviewed thousands of historical and forecasted data points to provide the most comprehensive oncology market outlook ever - pulling together data from our own proprietary PharmaEdge databases, along with hundreds of additional public and private databases worldwide.
Give your brand team all the oncology market research it needs to make critical product decisions!
Key Questions This Report Will Answer:
- Which drugs will make the most money in the next five years?
- Which drug classes are poised for exponential growth?
- Whose portfolio will allow them to jump out in front of the oncology market?
Call Adam Bianchi at 919-433-0202 to get your own copy of "Oncology Roadmap" today.
